PsyQ, Zaandam, University of Amsterdam, Amsterdam, The Netherlands.
Psychother Psychosom. 2015;84(1):30-6. doi: 10.1159/000365764. Epub 2014 Dec 24.
The current study presents the results of a meta-analysis of 39 randomized controlled trials on the efficacy of acceptance and commitment therapy (ACT), including 1,821 patients with mental disorders or somatic health problems.
We searched PsycINFO, MEDLINE and the Cochrane Central Register of Controlled Trials. Information provided by the ACBS (Association of Contextual Behavioral Science) community was also included. Statistical calculations were conducted using Comprehensive Meta-Analysis software. Study quality was rated using a methodology rating form.
ACT outperformed control conditions (Hedges' g = 0.57) at posttreatment and follow-up assessments in completer and intent-to-treat analyses for primary outcomes. ACT was superior to waitlist (Hedges' g = 0.82), to psychological placebo (Hedges' g = 0.51) and to treatment as usual (TAU) (we defined TAU as the standard treatment as usual; Hedges' g = 0.64). ACT was also superior on secondary outcomes (Hedges' g = 0.30), life satisfaction/quality measures (Hedges' g = 0.37) and process measures (Hedges' g = 0. 56) compared to control conditions. The comparison between ACT and established treatments (cognitive behavioral therapy) did not reveal any significant differences between these treatments (p = 0.140).
Our findings indicate that ACT is more effective than treatment as usual or placebo and that ACT may be as effective in treating anxiety disorders, depression, addiction, and somatic health problems as established psychological interventions. More research that focuses on quality of life and processes of change is needed to understand the added value of ACT and its transdiagnostic nature.
本研究对 39 项关于接纳与承诺疗法(ACT)疗效的随机对照试验进行了荟萃分析,共纳入 1821 名患有精神障碍或躯体健康问题的患者。
我们检索了 PsycINFO、MEDLINE 和 Cochrane 对照试验中心注册库,并纳入了来自行为科学协会(ACBS)的信息。统计计算使用 Comprehensive Meta-Analysis 软件进行。使用方法评分表对研究质量进行评分。
在完成治疗和意向治疗分析的主要结局中,ACT 在治疗后和随访评估中均优于对照组(Hedges' g = 0.57)。与等待名单(Hedges' g = 0.82)、心理安慰剂(Hedges' g = 0.51)和常规治疗(TAU)相比,ACT 均具有优势(我们将 TAU 定义为常规标准治疗;Hedges' g = 0.64)。与对照组相比,ACT 在次要结局(Hedges' g = 0.30)、生活满意度/质量指标(Hedges' g = 0.37)和过程指标(Hedges' g = 0.56)上也具有优势。ACT 与已确立的治疗方法(认知行为疗法)相比,这些治疗方法之间没有发现任何显著差异(p = 0.140)。
我们的研究结果表明,ACT 比常规治疗或安慰剂更有效,ACT 可能与已确立的心理干预一样有效治疗焦虑障碍、抑郁、成瘾和躯体健康问题。为了更好地理解 ACT 的附加价值及其跨诊断性质,需要开展更多关注生活质量和变化过程的研究。